NYSE:GRDN Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis $40.28 +0.50 (+1.26%) As of 11:54 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Guardian Pharmacy Services Stock (NYSE:GRDN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GRDN alerts:Sign Up Key Stats Today's Range$39.54▼$40.5450-Day Range$34.99▼$43.4352-Week Range$19.30▼$44.00Volume29,998 shsAverage Volume393,239 shsMarket Capitalization$2.01 billionP/E Ratio48.54Dividend YieldN/APrice Target$42.83Consensus RatingModerate Buy Company Overview Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia. Read More Guardian Pharmacy Services Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks45th Percentile Overall ScoreGRDN MarketRank™: Guardian Pharmacy Services scored higher than 45% of companies evaluated by MarketBeat, and ranked 1061st out of 1,682 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingModerate Buy Consensus RatingGuardian Pharmacy Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on no strong buy ratings, 7 buy ratings, 2 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Guardian Pharmacy Services is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageGuardian Pharmacy Services has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Guardian Pharmacy Services' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth11.02% Earnings GrowthEarnings for Guardian Pharmacy Services are expected to grow by 11.02% in the coming year, from $1.18 to $1.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Guardian Pharmacy Services is 48.54, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 40.09.Price to Earnings Ratio vs. SectorThe P/E ratio of Guardian Pharmacy Services is 48.54, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.08.Price to Earnings Growth RatioGuardian Pharmacy Services has a PEG Ratio of 2.66. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGuardian Pharmacy Services has a P/B Ratio of 11.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Guardian Pharmacy Services' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.26% of the float of Guardian Pharmacy Services has been sold short.Short Interest Ratio / Days to CoverGuardian Pharmacy Services has a short interest ratio ("days to cover") of 5.25.Change versus previous monthShort interest in Guardian Pharmacy Services has recently decreased by 4.74%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuardian Pharmacy Services does not currently pay a dividend.Dividend GrowthGuardian Pharmacy Services does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.80 News SentimentGuardian Pharmacy Services has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Guardian Pharmacy Services this week, compared to 2 articles on an average week.Search Interest2 people have searched for GRDN on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Guardian Pharmacy Services to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Guardian Pharmacy Services insiders have not sold or bought any company stock.Percentage Held by Insiders32.96% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsGuardian Pharmacy Services has minimal institutional ownership at this time.Read more about Guardian Pharmacy Services' insider trading history. Receive GRDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GRDN Stock News HeadlinesGuardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference CallJuly 15, 2026 | businesswire.comGuardian Pharmacy Services: Growth Is Durable, But Valuation Is FullJuly 13, 2026 | seekingalpha.comCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.July 21 at 1:00 AM | Paradigm Press (Ad)Analysts Are Bullish on These Healthcare Stocks: Amylyx Pharmaceuticals Inc (AMLX), Guardian Pharmacy Services, Inc. Class A (GRDN)July 3, 2026 | theglobeandmail.comGuardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness ConceptsJuly 1, 2026 | businesswire.comGuardian Pharmacy Announces Leadership Transition and PromotionsJune 22, 2026 | tipranks.comGuardian Pharmacy Services, Inc. Announces Leadership TransitionsJune 22, 2026 | businesswire.comGuardian Pharmacy Extends Revolving Credit Facility and FlexibilityMay 28, 2026 | tipranks.comSee More Headlines GRDN Stock Analysis - Frequently Asked Questions How have GRDN shares performed this year? Guardian Pharmacy Services' stock was trading at $30.01 at the beginning of 2026. Since then, GRDN stock has increased by 34.2% and is now trading at $40.28. How were Guardian Pharmacy Services' earnings last quarter? Guardian Pharmacy Services, Inc. (NYSE:GRDN) issued its quarterly earnings results on Wednesday, May, 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.24 by $0.05. The firm's quarterly revenue was up 2.2% on a year-over-year basis. Read the conference call transcript. When did Guardian Pharmacy Services IPO? Guardian Pharmacy Services (GRDN) raised $102 million in an IPO on Thursday, September 26th 2024. The company issued 6,800,000 shares at a price of $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities served as the underwriters for the IPO. Who are Guardian Pharmacy Services' major shareholders? Guardian Pharmacy Services' top institutional shareholders include Handelsbanken Fonder AB (0.02%). Insiders that own company stock include William E Bindley, Thomas J Salentine Jr, Fred Burke, Kendall Forbes, John Ackerman, Equity Fund LP Cardinal, David K Morris and Steven D Cosler. View institutional ownership trends. How do I buy shares of Guardian Pharmacy Services? Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guardian Pharmacy Services own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META). Company Calendar Last Earnings5/06/2026Today7/21/2026Next Earnings (Confirmed)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (9m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 GRDN's financial health is in the Green zone, according to TradeSmith. GRDN has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - DRUGS Sub-IndustryRetail Current SymbolNYSE:GRDN Previous SymbolNYSE:GRDN CIK1802255 Webguardianpharmacy.com Phone(404) 810-0089FaxN/AEmployees3,600Year Founded2004Price Target and Rating Average Price Target for Guardian Pharmacy Services$42.83 High Price Target$47.00 Low Price Target$36.00 Potential Upside/Downside+6.3%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$0.83 Trailing P/E Ratio48.54 Forward P/E Ratio34.14 P/E Growth2.66Net Income$49.22 million Net Margins3.64% Pretax Margin5.40% Return on Equity30.72% Return on Assets15.99% Debt Debt-to-Equity RatioN/A Current Ratio1.46 Quick Ratio1.17 Sales & Book Value Annual Sales$1.45 billion Price / Sales1.38 Cash Flow$1.25 per share Price / Cash Flow32.17 Book Value$3.44 per share Price / Book11.71Miscellaneous Outstanding Shares49,780,000Free Float33,373,000Market Cap$2.01 billion OptionableN/A Beta0.05 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NYSE:GRDN) was last updated on 7/21/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRDN Stock Alerts